Tuesday, August 25, 2020
Study: New 'echo-focusing' approach for focused ultrasound is feasible, safe, and more efficient
New approach may enable more patients with essential tremor to benefit from cutting-edge therapy
Tuesday, August 25, 2020
$1.1 million grant to support Sunnybrook world-first study investigating early-stage interventions for cognitive decline
Congratulations to Dr. Krista Lanctôt, senior scientist and recipient of the Alzheimer's Association's 2020 Part the Cloud-Gates Partnership Grant Program
Wednesday, July 29, 2020
A common diabetes medication may slow memory decline in Alzheimer's disease
Researchers at Sunnybrook Research Institute and the University of Toronto found that the rate of memory decline was slower in people with Alzheimer’s disease taking a specific class of anti-diabetic drug, known as a dipeptidyl peptidase-4 (DPP4) inhibitor.
Wednesday, July 22, 2020
Two Sunnybrook-led studies awarded funding through the Ontario COVID-19 Rapid Research Fund
The $20-million fund will support researchers working to find ways to prevent, detect and treat COVID-19.
Tuesday, July 14, 2020
Sunnybrook researchers have developed a new way to detect hearing loss in blood
Scientists demonstrated a way to detect hearing disorders using a simple blood test
